Loading...
Market
Primary impact of released Pfizer trial documents by end of 2025?
2
Resolution / Starting Odds
Increased transparency and trust • 25%
Legal challenges against FDA • 25%
Policy changes in vaccine approval • 25%
No significant impact • 25%
Analysis from major news outlets and expert commentary
Story
Court Orders FDA to Release Hidden Pfizer Vaccine Trial Documents
Dec 6, 2024, 11:17 PM
A U.S. District Judge Mark Pittman has ordered the FDA to release an additional million pages of documents from Pfizer’s COVID-19 vaccine trials. This decision comes after the FDA attempted to keep these documents hidden from the public for over 75 years. The court's ruling is seen as a significant victory for transparency, following a lawsuit against the FDA. The documents are expected to shed light on the authorization process of the vaccines, which has been a point of contention and public interest.
View original story
Similar markets
Vaccine efficacy data • 25%
Adverse side effects • 25%
Trial participant demographics • 25%
Regulatory approval process • 25%
0-25% • 25%
26-50% • 25%
51-75% • 25%
76-100% • 25%
Independent Researchers • 25%
Mainstream Media • 25%
Government Agencies • 25%
Pfizer • 25%
Increase trust • 25%
Decrease trust • 25%
No significant change • 25%
Mixed impact • 25%
Vaccine Safety • 25%
Data Transparency • 25%
FDA's Handling • 25%
Effectiveness of Vaccines • 25%
Yes • 50%
No • 50%
FDA • 25%
Pfizer • 25%
CDC • 25%
WHO • 25%
Less than 500,000 • 25%
500,000 to 1 million • 25%
1 million to 1.5 million • 25%
More than 1.5 million • 25%